Reilly Kevin C

SEC Form 4 insider trading activity

Reilly Kevin C has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.

On the most recent filing, Reilly Kevin C is listed as Director at KESTRA MEDICAL TECHNOLOGIES, LTD. Inside the rolling window, Reilly Kevin C reported no open-market purchases and 1 open-market sale totaling $74K in KMTS.

Companies traded

Other insiders at KMTS

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$74K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
KMTS
Reilly Kevin C
Sale$74KSep 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Reilly Kevin C made?

Reilly Kevin C has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.

Which companies does Reilly Kevin C trade?

Reilly Kevin C has filed SEC Form 4 disclosures for 1 company, including KMTS.

When was Reilly Kevin C's most recent SEC Form 4 filing?

Reilly Kevin C's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.

What is Reilly Kevin C's total buy and sell value in the current window?

Inside the rolling retention window, Reilly Kevin C bought $0 and sold $74K based on SEC Form 4 filings.

What was Reilly Kevin C's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 2,932 KMTS shares on 2026-09-08, worth $74K, per SEC Form 4 filings.